(Updated - December 13, 2021 4:41 AM EST)

UBS analyst Colin Bristow downgraded Merck (NYSE: MRK) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE